These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9039387)

  • 1. Targeted hepatitis B vaccination--a cost effective immunisation strategy for the UK?
    Williams JR; Nokes DJ; Anderson RM
    J Epidemiol Community Health; 1996 Dec; 50(6):667-73. PubMed ID: 9039387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes.
    Williams JR; Nokes DJ; Medley GF; Anderson RM
    Epidemiol Infect; 1996 Feb; 116(1):71-89. PubMed ID: 8626006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage.
    Gilson RJ; de Ruiter A; Waite J; Ross E; Loveday C; Howell DR; Tedder RS; Weller IV
    Sex Transm Infect; 1998 Apr; 74(2):110-5. PubMed ID: 9634322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies.
    Edmunds WJ
    Commun Dis Public Health; 1998 Dec; 1(4):221-8. PubMed ID: 9854877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.
    Siddiqui MR; Gay N; Edmunds WJ; Ramsay M
    Vaccine; 2011 Jan; 29(3):466-75. PubMed ID: 21073988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination schedules in genitourinary medicine clinics.
    Asboe D; Rice P; de Ruiter A; Bingham JS
    Genitourin Med; 1996 Jun; 72(3):210-2. PubMed ID: 8707326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment.
    Adler MW; Belsey EM; McCutchan JA; Mindel A
    Br Med J (Clin Res Ed); 1983 May; 286(6378):1621-4. PubMed ID: 6405916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
    Mangen MJ; Stibbe H; Urbanus A; Siedenburg EC; Waldhober Q; de Wit GA; van Steenbergen JE;
    Vaccine; 2017 May; 35(24):3215-3221. PubMed ID: 28483198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales.
    Mangtani P; Hall AJ; Normand CE
    J Epidemiol Community Health; 1995 Jun; 49(3):238-44. PubMed ID: 7629457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-benefit analysis of vaccinal prevention of hepatitis B policy].
    Kerleau M; Flori YA; Nalpas B; Lanoé JL; Berthelot P; Fardeau-Gautier M
    Rev Epidemiol Sante Publique; 1995; 43(1):48-60. PubMed ID: 7892516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-benefit analysis of hepatitis B vaccination.
    Jönsson B
    Postgrad Med J; 1987; 63 Suppl 2():27-32. PubMed ID: 3120169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination of men who have sex with men: experience with an accelerated course of vaccination in a genitourinary medicine clinic.
    McMillan A
    Int J STD AIDS; 2005 Sep; 16(9):633-5. PubMed ID: 16176633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic.
    Evans BA; McCormack SM; Bond RA; MacRae KD; Thorp RW
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):473-5. PubMed ID: 3126866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey on hepatitis B vaccination policies in genitourinary medicine in UK and Ireland.
    el-Dalil A; Radcliffe KW; Bailey J; Richmond RA; Wade AA
    Genitourin Med; 1995 Aug; 71(4):251-3. PubMed ID: 7590719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.
    Mulley AG; Silverstein MD; Dienstag JL
    N Engl J Med; 1982 Sep; 307(11):644-52. PubMed ID: 6810170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis A immunity in male genitourinary medicine clinic attenders: a case control study of heterosexual and homosexual men.
    Ross JD; Ghanem M; Tariq A; Gilleran G; Winter AJ
    Sex Transm Infect; 2002 Jun; 78(3):174-9. PubMed ID: 12238647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.